Second messenger molecules relay, amplify, and diversify cell surface receptor signals. Two important examples are phosphorylated D-myo-inositol derivatives, such as phosphoinositide lipids within cellular membranes, and soluble inositol phosphates. Here, we review how phosphoinositide metabolism generates multiple second messengers with important roles in T-cell development and function. They include soluble inositol(1,4,5)trisphosphate, long known for its Ca 2þ -mobilizing function, and phosphatidylinositol(3,4,5)trisphosphate, whose generation by phosphoinositide 3-kinase and turnover by the phosphatases PTEN and SHIP control a key "hub" of TCR signaling. More recent studies unveiled important second messenger functions for diacylglycerol, phosphatidic acid, and soluble inositol(1,3,4,5)tetrakisphosphate (IP 4 ) in immune cells. Inositol(1,3,4,5)tetrakisphosphate acts as a soluble phosphatidylinositol(3,4,5)trisphosphate analog to control protein membrane recruitment. We propose that phosphoinositide lipids and soluble inositol phosphates (IPs) can act as complementary partners whose interplay could have broadly important roles in cellular signaling.
S
econd messenger molecules relay, amplify, and diversify signals perceived by cell surface receptors. One important second messenger family is comprised of the phosphorylated derivatives of the small cyclic poly-alcohol Dmyo-inositol. They include phosphoinositide lipids within cellular membranes, and soluble inositol phosphates, here termed IPs. In most stimulatory cells, the plasma membrane phosphoinositide, phosphatidylinositol(4,5)bisphosphate (here termed PIP 2 for improved readability, although several different PIP 2 isomers exist) is a key precursor for both other phosphoinositides and soluble IPs. Many of these regulate distinct and overlapping downstream effectors (Irvine and Schell 2001; Alcazar-Roman and Wente 2008; Resnick and Saiardi 2008; Sauer et al. 2009; Shears 2009; Sauer and Cooke 2010) . In particular, class I phosphoinositide 3-kinases (PI3K) phosphorylate PIP 2 at the 3-position of its inositol-ring into phosphatidylinositol(3,4,5)trisphosphate (here termed PIP 3 ) ( Fig. 1 ) after receptor stimulation (Vanhaesebroeck et al. 2005; Juntilla and Koretzky 2008; Buitenhuis and Coffer 2009; Fruman and Bismuth 2009) . Receptor-induced PIP 2 -hydrolysis by phospholipases such as PLCg1/2 in lymphocytes generates the lipid diacylglycerol (DAG) and the soluble IP inositol(1,4,5)trisphosphate (IP 3 ). PIP 3 , DAG, and IP 3 have essential second messenger functions in many cells, including lymphocytes. Here, we review the importance of phosphoinositide signaling in T cells and highlight the importance of a recently identified, intriguing molecular interplay between second messenger lipids and their soluble IP counterparts.
PHOSPHOINOSITIDES CONTROL SIGNALING BY BINDING TO SPECIFIC PROTEIN DOMAINS
All phosphoinositides contain a hydrophobic membrane-embedded diacylglyceride and a hydrophilic solvent-exposed IP moiety. The inositol ring hydroxyl groups can be stereo-specifically phosphorylated by phosphoinositidekinases. Most phosphatidylinositol-bisphosphate in the plasma membrane of unstimulated Figure 1 . The phosphoinositide PI(4,5)P 2 is a key node of second messenger metabolism in lymphocytes. PI(4,5)P 2 -phosphorylation by PI3-kinases and PI(4,5)P 2 -hydrolysis by PLCg initiate several second messenger cascades within cellular membranes and soluble compartments. These second messengers can have various functions, including the recruitment and/or activation of effector proteins by binding to specific domains within them (blue arrows and green boxes). In particular, the phosphatases SHIP1/2 or PTEN limit or downregulate PIP 3 levels and the functions of PIP 3 and its effectors by hydrolyzing PIP 3 into PI(3,4)P 2 or PI(4,5)P 2 , respectively. For group 1D, PH domains such as that of Akt, PI(3,4)P 2 binding sustains effector activity (Cozier et al. 2004; DiNitto and Lambright 2006; Lemmon 2008) . PI(4,5)P 2 recruits proteins such as RASA3/GAP1
IP4BP by binding to their PH domains (Lockyer et al. 1997; Cozier et al. 2000a; Cozier et al. 2000b ). Hence, both PIP 2 s and PIP 3 can have partially overlapping functions depending on the lipid-binding protein domain involved. PLCg hydrolyzes PI(4,5)P 2 into protein C1 domain binding DAG and into IP 3 , which binds EF and C2 domain containing proteins and mobilizes Ca 2þ . IP 3 3-kinases convert IP 3 into IP 4 , which acts as a soluble PIP 3 analog and controls the abilities of certain PH domains to bind to PIP 3 either positively (green arrow) or negatively (red arrow). An unknown 5-phosphatase metabolizes IP 4 into I(1,3,4)P 3 , a precursor for higher-order IPs. In vitro, SHIP1 and PTEN can dephosphorylate IP 4 at the 5-or 3-positions, respectively Maehama and Dixon 1998; Pesesse et al. 1998; Caffrey et al. 2001) . Whether this occurs physiologically is unknown. Finally, DAG kinases (DGKs) down-regulate DAG function by phosphorylating it into PA, itself a ligand for certain proteins. Further metabolism of all these second messengers results in the generation of many lipid and soluble metabolites. Several of these have important signaling functions (Irvine 2001; Irvine and Schell 2001; York and Hunter 2004; York 2006; Alcazar-Roman and Wente 2008; Huang et al. 2008; Jia et al. 2008b; Miller et al. 2008; Burton et al. 2009; Shears 2009; Sauer and Cooke 2010; Schell 2010) . Their functions in immunocytes are unknown.
cells is phosphorylated at the inositol 4-and 5-positions. This PIP 2 comprises ,1% of the inner leaflet of the plasma membrane, contrasting with much more abundant phospholipids such as phosphatidylserine and phosphatidic acid (PA) (Lemmon 2008) . Despite its low abundance, PIP 2 is an important second messenger. It recruits and regulates multiple signaling proteins by binding to their pleckstrin homology (PH), epsin N-terminal homology (ENTH), 4.1, ezrin, radixin, moesin (FERM), Tubby, or Phox-homology (PX) domains with varying affinities and specificities (McLaughlin et al. 2002) . Due to the constitutive PIP 2 availability in resting cells, these PIP 2 -associated proteins likely maintain signaling pathways in a preactivation state. Evidence supporting this notion in T cells comes from the inhibitory effects of PIP 2 binding to the guanine nucleotide exchange factor, Vav (Han et al. 1998) , and the guanine nucleotide activating factor, ArhGAP9, which maintains Rho-family GTPases in an inactive state (Ang et al. 2007; Ceccarelli et al. 2007) . Despite the importance of PIP2, much greater attention has been given to the products of PIP 2 phosphorylation or PIP 2 hydrolysis that are induced following receptor activation. PIP 2 phosphorylation is mediated by PI3Ks. PI3Ks fall into four classes based upon their substrate specificity. Each class comprises one or more regulatory and catalytic subunits with partially distinct and overlapping functions (Fig. 2) . Class II and III PI3Ks phosphorylate phosphatidylinositol (PI) into PI(3)P and PI(3,4)P 2 . Their functions in lymphocytes are largely unexplored. Class I PI3Ks phosphorylate PIP 2 into PIP 3 , an inducible ligand that mediates recruitment and activation of various important signaling proteins. Class IA PI3Ks are activated by most stimulatory receptors on lymphocytes including T-and B-cell antigen receptors (TCR, BCR), and co-stimulatory, Toll-like, and cytokine receptors (Vanhaesebroeck et al. 2005; Buitenhuis and Coffer 2009; Fruman and Bismuth 2009). Five regulatory ( p50a, p55a, p55g, p85a, p85b) and three catalytic (p110a, b, and d) subunits participate in Class IA PI3K signaling. Recruitment of Class IA regulatory subunits via binding of their SH2 domains to receptor-induced tyrosine-phosphorylated ITAM motifs leads to colocalization of PI3K catalytic subunits with their substrate, membrane PIP 2 . In contrast, Class IB PI3Ks are activated downstream of G-protein-coupled receptors, including chemokine receptors. Class IB comprises two regulatory subunits (p101, p84/87) and one catalytic ( p110g) subunit (Stephens et al. 1994; Stoyanov et al. 1995; Stephens et al. 1997; Suire et al. 2005) . Following GPCR engagement, class IB PI3K regulatory subunits bind through their C-terminal domains to Gbg subunits. Both class IA (Okkenhaug et al. 2002; Okkenhaug et al. 2006; Patton et al. 2006; Matheu et al. 2007; Liu et al. 2009a; Liu and Uzonna 2010; Soond et al. 2010 ) and class IB (Sasaki et al. 2000; Swat et al. 2006; Alcazar et al. 2007 ) PI3Ks have important functions in T-cell development and function. The T-cell phenotypes of mice with individual or combined PI3K subunit deficiencies are summarized in Table 1 .
THE SECOND MESSENGER PIP 3 RECRUITS PROTEINS TO MEMBRANES BY BINDING TO THEIR PH DOMAINS
Taken together, immunoreceptor-induced PIP 3 generation is important for lymphocyte proliferation and differentiation (for reviews, see Juntilla and Koretzky 2008; Buitenhuis and Coffer 2009; Fruman and Bismuth 2009) . PIP 3 mediates the cellular effects of PI3K activation by recruiting effector proteins that stereospecifically bind to PIP 3 through a subclass of pleckstrin homology or PH domains-protein modules of approximately 120 amino acids that were originally identified as a repeated domain in Pleckstrin (Haslam et al. 1993; Mayer et al. 1993) . The mammalian genome contains approximately 250 PH domain proteins. Although there is little amino acid sequence conservation among PH domains, they share a common b-barrel fold comprised of two b sheets and a C-terminal a-helical cap (Downing et al. 1994; Ferguson et al. 1994; Macias et al. 1994; Timm et al. 1994; Yoon et al. 1994) . In approximately 60 PH domains, the N-terminal portion contains a pocket that binds phosphoinositols (Cozier et al. 2004; Hirata et al. 1998 (Pouillon et al. 2003; Wen et al. 2004; Chamberlain et al. 2005; Huang et al. 2006; Huang et al. 2007; Jia et al. 2007; Marechal et al. 2007; Miller et al. 2007b; Huang et al. 2008; Jia et al. 2008a; Jia et al. 2008b; Miller et al. 2008; Miller et al. 2009 (Ji et al. 1997; Shirane et al. 2001; Fu et al. 2010) PLCg2 2/2 mice No T-cell defect reported. Defects in mast cells, dendritic cells, osteoclasts, and neutrophils. Graham et al. 2007; Cremasco et al. 2008; Epple et al. 2008; Cremasco et al. 2010) domain determine its ligand specificity by interacting with specific negatively charged phosphate groups within the inositol ring. The Akt (Protein kinase B) and Tec protein kinase families are part of a small but immunologically important subset of PH-domain-containing proteins whose activities are regulated by PIP 3 binding, which colocalizes the kinases with their upstream activators (August et al. 1997; Heyeck et al. 1997; Stokoe et al. 1997 ). In addition, the Akt PH domain can also bind to PI(3,4)P 2 (Cozier et al. 2004; DiNitto and Lambright 2006; James et al. 1996; Lemmon 2008) .
PIP 3 CONTROLS AKT FUNCTION IN LYMPHOCYTES
Akt and its upstream activator PDK1 (Phosphoinositide-dependent kinase 1) are nonreceptor serine/threonine kinases of the AGC family. They regulate survival and proliferation of many cell types (Manning and Cantley 2007) . Both kinase families are structurally relatively simple-containing only a kinase domain, a PH domain, and in the case of Akt1, a short hydrophobic motif. Before activation, the Akt and PDK1 PH domains seem to function in an inhibitory manner that is released upon membrane PIP 3 binding (Stokoe et al. 1997; Gao and Harris 2006) . Full PDK1 activation requires PIP 3 binding to the PDK1 PH domain, which allows trans-phosphorylation of a Cterminal residue (Gao and Harris 2006) . In the absence of lipid ligands, the Akt1 PH domain occludes access to the activation site, prohibiting its phosphorylation by PDK1 (Stokoe et al. 1997; Calleja et al. 2007 ). PHdomain-mediated PDK1 and Akt recruitment to membrane PIP 3 leads to phosphorylation of the catalytic T-loop of Akt by PDK1, activating Akt (Stephens et al. 1998) . A second kinase of uncertain identity phosphorylates the Akt C-terminal hydrophobic motif, leading to optimal Akt kinase activity. There are three Akt paralogs in mammals (Akt1/2/3). All are expressed in lymphocytes and have partially redundant functions. Akt promotes cell survival primarily through inhibition of apoptosis. Akt can directly or indirectly inhibit the function of proapoptotic Bcl-2 family members by phosphorylation (del Peso et al. 1997; Gardai et al. 2004; Qi et al. 2006; Hubner et al. 2008) . Akt also activates the transcription factor NF-kB (Madrid et al. 2000) and induces expression of antiapoptotic Bcl-2, FLIP, and IAP proteins (Wang et al. 1998; Panka et al. 2001) . Akt, moreover, promotes cell proliferation by increasing cell metabolism (Frauwirth et al. 2002; Rathmell et al. 2003; Jacobs et al. 2008) , facilitating protein translation (Dufner et al. 1999) , and cell cycle progression (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002) . Consequently, genetic alterations that enhance Akt activity either directly or indirectly via amplification of PI3K activity often lead to cellular transformation (Liu et al. 2009b ).
Akt1 and Akt2 are particularly important during early T-cell development (Juntilla et al. 2007; Juntilla and Koretzky 2008) . CD4 and CD8 T cells develop from a common thymic (Juntilla et al. 2007 ). This highlights the importance of Akt kinases during the highly proliferative stage of thymic development.
TEC FAMILY PROTEIN TYROSINE KINASES ARE KEY PIP 3 EFFECTORS IN LYMPHOCYTES
The expression of certain Tec family nonreceptor protein -tyrosine -kinases (TFKs) is restricted to specific immune cell types (Readinger et al. 2009 ). Itk and Rlk are largely restricted to T cells and NK cells. Btk is not expressed in these, but enriched in B cells, mast cells, and myeloid cells. Tec is broadly expressed in hematopoietic cells. Despite some functional redundancies, deficiency in individual TFKs causes profound functional defects (for a review, see Readinger et al. 2009 ). Itk deficiency causes defects in T-cell development and in certain peripheral T-cell functions (Liao and Littman 1995; Fowell et al. 1999; Schaeffer et al. 1999; Schaeffer et al. 2000; Schaeffer et al. 2001; Tomlinson et al. 2004; Finkelstein et al. 2005; Atherly et al. 2006; Broussard et al. 2006; Horai et al. 2007; Lucas et al. 2007) .
At the DP stage, thymocytes are evaluated for the ability of their TCR to interact with self MHC/peptide complexes on the surfaces of thymic antigen-presenting cells. DP cells whose TCRs do not interact with sufficient strength or duration die by "neglect." DP cells whose TCRs interact moderately with self-MHC class I or II are positively selected to mature into CD8 or CD4 single positive T cells, respectively. DP cells carrying potentially autoreactive TCRs that interact too strongly or for an inappropriate duration with self-MHC are induced to die by "negative selection." A major unresolved question in immunological research is how TCR engagement can have such different outcomes.
Positively and negatively selecting TCR signals appear to activate the same proximal signaling molecules, including Itk. In Itk-deficient mice, the efficiencies of positive and negative selection are dramatically decreased (Liao and Littman 1995; Schaeffer et al. 2000) . In contrast, Itk deficiency favors the accumulation of a nonconventional thymic T cell subset with an effector/ memory or "innate" phenotype, particularly in the CD8 lineage (Atherly et al. 2006; Broussard et al. 2006; Horai et al. 2007 ). In addition, TCR signals that normally induce negative selection can, under some circumstances, promote positive selection in Itk-deficient mice (Schaeffer et al. 2000) . In mature T cells, Itk appears to be required to sustain T H 2 responses (Fowell et al. 1999; Schaeffer et al. 2001) .
TFKs have a relatively complex domain structure with an N-terminal PH domain, followed by a proline-rich Tec homology domain, Src homology 3 (SH3) and SH2 domains, and a C-terminal kinase domain. In Rlk, a missing N-terminal PH domain is functionally substituted by palmitoylation, resulting in constitutive membrane association (Debnath et al. 1999) . Membrane recruitment of the other TFKs predominantly depends on interactions between their PH domains and membrane PIP 3 (Ching et al. 1999; Shan et al. 2000) , together with interactions between their SH2 domains and adaptor proteins such as SLP-76 in T cells (Ching et al. 1999; Su et al. 1999) . However, recent data may suggest that Btk membrane recruitment can also occur in a PH-domain-independent manner (Fruman and Bismuth 2009 ). Activation-induced association with cytosolic SLP-76 and the membrane adaptor LAT colocalizes TFKs with their upstream activators, Src kinases, and their downstream target, PLCg1 (Wange 2000; Qi and August 2007) . Mechanistically, the consequences of TFK deficiency have primarily been attributed to defective PLCg phosphorylation and activation (Liu et al. 1998 ). In addition, TFKs appear required for Vav-dependent cytoskeletal organization and cell adhesion (Gomez-Rodriguez et al. 2007 ). However, TFK promotion of Vav function appears to involve TFK adaptor functions, rather than their kinase activities (Grasis et al. 2003; Dombroski et al. 2005) . PI(4,5)P 2 is a substrate for another immunologically important enzyme, phosphatidylinositolspecific phospholipase-Cg (PLCg). PLCg hydrolyzes PIP 2 into its hydrophobic and hydrophilic components, the membrane-lipid diacylglycerol (DAG) and soluble inositol(1,4,5)trisphosphate (IP 3 ). Both are second messengers that regulate proteins through specific binding domains.
The two mammalian PLCg isoforms, PLCg1 and 2, have partially overlapping expression patterns and functions (Wilde and Watson 2001) . T cells exclusively express PLCg1. Tcell-specific PLCg1-deletion impaired thymocyte positive and negative selection, regulatory T reg cell development and function, TCRinduced peripheral T-cell proliferation, and cytokine production (Fu et al. 2010) . Defective TCR activation of the MAP kinases Erk and Jnk, and of the transcription factors NFAT, AP-1, and NF-kB indicates the broad importance of PLCg1 in TCR signaling through several pathways. Autoimmune disease symptoms show the physiological importance of PLCg1 in T cells (Fu et al. 2010) . Severe blocks in T-cell development and late onset autoimmunity in mice expressing a PLCg1-binding-deficient LAT allele indicate the importance of LAT interactions for PLCg1 function (Sommers et al. 2002; Sommers et al. 2005) . Finally, severe defects in early hematopoiesis in chimeric mice generated with PLCg1-deficient embryonic stem cells suggest important PLCg1 functions in hematopoietic stem or progenitor cells (Shirane et al. 2001) . In contrast, PLCg2-deficient mice are viable with specific defects in B cells, mast cells, dendritic cells, osteoclasts, and neutrophils Graham et al. 2007; Cremasco et al. 2008; Epple et al. 2008; Cremasco et al. 2010) .
PLCg1/2 have complex domain structures with an N-terminal PH domain, followed by a number of EF hands, a catalytic domain that is split by an internal regulatory domain, and a C-terminal Ca 2þ -binding-C2 domain (Fig. 2) . The regulatory domain contains a core of two tandem SH2 domains and an SH3 domain that is flanked by a split PH domain. This split PH domain can self-associate to form a functional PH domain, or associate in trans with a split PH domain in TRPC-family Ca 2þ channels (van Rossum et al. 2005) . Either one or both PH domains contribute to PLCg1 membrane association by binding to PIP 3 (Bae et al. 1998; Falasca et al. 1998) . Additional interactions are provided by the other modular domains. Once PLCg1 is at the membrane, phosphorylation of tyrosine residues within its regulatory domain by TFKs induces PLCg1 activation. Recent studies suggest that this requires phosphotyrosine-independent PLCg1 SH2 domain binding to a noncanonical ligand motif in Itk (Joseph et al. 2007; Min et al. 2009 ).
DIACYLGLYCEROL CONTROLS Ras AND PKC ACTIVATION IN LYMPHOCYTES
The membrane second messenger, DAG, propagates signals via membrane recruitment of cytosolic signaling proteins by binding to their C1 domains, cysteine-rich domains of approximately 50 amino acids. Two b-sheets harbor the DAG-binding cavity.
Several well-characterized DAG-effector families include Ras guanine-nucleotide-exchangefactors/releasing proteins (RasGRPs), protein kinase C-related kinases (PKCs, PKD), chimaerin Rho/Rac-GTPase-activating proteins Kazanietz 2007), Munc13 proteins (Betz et al. 1998) , and diacylglycerol kinases (DGKs). There is some effector selectivity for different DAG species that differ in their subcellular localization.
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For example, RasGRPs preferentially bind to DAG in Golgi membranes (Carrasco and Merida 2004) . PKCs preferentially bind to DAG in the plasma membrane (Spitaler et al. 2006) .
RasGRP membrane recruitment by DAG colocalizes these Ras activators with their substrate, inducing release of Ras-bound GDP, GTP binding, and Ras activation. Ras then activates the kinase Raf, which activates the downstream Erk cascade. The four mammalian RasGRPs1 -4 have partially overlapping expression patterns and partially redundant functions. T cells predominantly express RasGRP1, the main mediator of TCR-induced Ras/Erk activation (Dower et al. 2000; Priatel et al. 2002) . RasGRP1 deficiency causes a significant block of T-cell development with strong defects in positive, and some defects in negative selection (Dower et al. 2000; Priatel et al. 2002) . However, this developmental block is incomplete and can be partially rescued by strong TCR activation (Priatel et al. 2006 ). Nevertheless, a moderate lymphopenia occurs due to T-cell exhaustion (Priatel et al. 2007 ). Interestingly, T reg cells accumulate in the periphery of RasGRP1-deficient mice, despite perturbed T reg development (Chen et al. 2008) .
In contrast to RasGRPs, DAG-mediated membrane recruitment allosterically induces PKC activitation by abrogating an autoinhibitory association between the PKC pseudo-substrate and substrate-binding domains (Rosse et al. 2010) . DAG promotes activation of classic (PKCa, PKCbI, PKCbII, PKCg), novel (PKCd, PKC1, PKCh, PKCu), and atypical PKCs (PKCj, l/i). However, classic and novel PKCs also require Ca 2þ binding to their C2 domains (Rosse et al. 2010) . Multiple studies have shown essential PKC roles in lymphocyte development and function (for reviews, see Isakov and Altman 2002; Barouch-Bentov and Altman 2006; Manicassamy et al. 2006) . In particular, PKCu is important for TCR signaling and required for thymocyte-positive selection (Morley et al. 2008) . Incomplete developmental defects likely reflect redundancy among thymocyte-expressed PKCs.
Several recent publications suggest important functions for chimaerins in TCR signaling, T-cell adhesion, and chemotaxis that involve their ability to inactivate Rac (Siliceo et al. 2006; Caloca et al. 2008; Siliceo and Merida 2009) . No munc13 protein roles in the immune system have been reported.
DIACYLGLYCEROL KINASES CONVERT DAG INTO PHOSPHATIDIC ACID
Aside from their production by PLCg in lymphocytes, DAG levels are also regulated through their phosphorylation into phosphatidic acid (PA) by DAG kinases (DGKs). In T cells, this down-regulates PKC and RasGRP functions and TCR-induced-Erk activation (reviewed in Zhong et al. 2008 ). However, in many cell types, receptor-induced PA generation activates a series of PA-effector proteins with various functions, including vesicular trafficking, cell survival, and proliferation (Wang et al. 2006) .
The ten mammalian DGKs form five groups based on their domain structure (Fig. 3) . All DGKs have two to three C1 domains and a kinase domain. However, these C1 domains do not necessarily participate in DAG binding. Instead, the domains that distinguish the DGK types direct differential localization or activation requirements. T cells express at least three DAG kinases: DGKa (type I), d (type II), and j (type IV). DGKa has an N-terminal RVH domain and two EF hands. Ca 2þ binding to these three domains induces DGKa activation. DGKd has an N-terminal PH domain, two EF hands, and a C-terminal SAM domain. The PH domain facilitates DAG binding. The SAM domain mediates DGKd oligomerization and ER targeting. DGKj has a central MARCKS domain, multiple ankyrin repeats, and a Cterminal PDZ-BM domain. The MARCKs domain contains a nuclear localization sequence. The PDZ-BM domain of DGKj regulates Rac activity and membrane ruffling.
DGKa and DGKj cooperatively downregulate T-cell activation and facilitate T-cell tolerance . Different T-cell developmental and activation stages express different DGKa and DGKj splice variants (Macian et al. 2002) . DGKa-(Outram et al. (Zhong et al. 2003; Olenchock et al. 2006 ) deficient mice have increased DAG-dependent signaling and produce hyper-responsive T cells. DGKa/j double deficiency causes lymphopenia due to a partial block in T-cell development . The peripheral T cells contain reduced T reg proportions and are resistant to anergy induction (Olenchock et al. 2006; Zha et al. 2006) . Therefore, limiting DAG function in T cells is of great physiological importance, although defective PA production may contribute to the phenotype .
IP 3 MEDIATES ANTIGEN-RECEPTOR-INDUCED Ca 2þ MOBILIZATION AND CAN ACT AS A PRECURSOR FOR HIGHER-ORDER INOSITOL PHOSPHATES IN LYMPHOCYTES
Ca
2þ is a rapid and robust, soluble second messenger with multiple downstream effectors (Feske 2007; Oh-hora and Rao 2008; Vig and Kinet 2009) . mM extracellular Ca 2þ concentrations contrast with nM cytosolic Ca 2þ concentrations that are tightly maintained by pumps, which sequester Ca 2þ into the extracellular space or intracellular storage compartments (Feske 2007; Oh-hora and Rao 2008) . Following TCR engagement, Ca 2þ signaling is initiated by the soluble product of PIP 2 hydrolysis, Ins(1,4,5)P 3 (here IP 3 ). IP 3 binding to receptors in the ER membrane releases the stored Ca 2þ into the cytosol (Taylor et al. 2009 ). Subsequent sensing of the store depletion by STIM proteins induces STIM translocation to the plasma membrane, where STIM-induced opening of ORAI-family Ca 2þ channels triggers a store-operated Ca 2þ entry (SOCE). This causes a sustained increase of the cytoplasmic Ca 2þ concentration that is essential for T-cell activation (Feske 2007; Oh-hora and Rao 2008; Vig and Kinet 2009) .
Cytosolic Ca 2þ binds to proteins with C2 domains and EF hands, inducing conformational changes that alter activity (Niki et al. 1996) . Important examples with EF hands are the cytosolic adapter Calmodulin and STIM proteins (Feske 2007; Oh-hora and Rao 2008; Vig and Kinet 2009) . Otto et al. 2007; Huang et al. 2008; Jia et al. 2008b; Miller et al. 2008; Sauer and Cooke 2010; Schell 2010) . Much research has explored potential IP3K roles in regulating Ca 2þ mobilization either by controlling IP 3 turnover, or through distinct functions of IP 4 or IP 4 -derived other IPs. The results caused a long-standing controversy that could be attributed to differences in cell type, stimulation regimen, or experimental conditions. Studies with human Jurkat T cells suggest that IP 4 can sustain TCR-induced IP 3 accumulation and Ca 2þ mobilization through competitive inhibition of an inositol 5-phosphatase (Hermosura et al. 2000) . Moreover, a recent study suggested that ITPKC knockdown in Jurkat cells promotes TCRinduced activation of the Ca 2þ -effector NFAT and IL-2 production (Onouchi et al. 2008) . These data are consistent with one IP3K role in controlling IP 3 levels or function. The precise mechanism, identity of the 5-phosphatase, and physiological relevance remain unclear. Normal anti-TCR antibody-induced IP 3 accumulation and Ca 2þ mobilization in ItpkB-deficient thymocytes suggest that ItpkB may not regulate Ca 2þ mobilization in murine thymocytes (Pouillon et al. 2003; Wen et al. 2004 ). However, IP 4 levels and total IP3K activity were only approximately 50% reduced. Thus, other IP3Ks likely contribute to IP 4 production in thymocytes, and the consequences of complete IP3K/IP 4 deficiency on Ca 2þ mobilization still needs to be determined.
IP 4 chemically resembles the PH-domainbinding headgroup of PIP 3 , and less well those of PI(4,5)P 2 and PI(3,4)P 2 . Not surprisingly, IP 4 can bind to some of the protein domains that bind to these phosphoinositides. This property is often used to facilitate PH domain crystallization for X-ray structure determination (Lemmon 2008) . Biochemical data suggest that IP 4 binding to the PH domains of Ras GTPaseactivating proteins (RASA2/GAP1 m , RASA3/ GAP1 IP4BP ) (Cullen et al. 1995; Cozier et al. 2000b) , BTK, AKT, or certain regulators of vesicular trafficking (synaptotagmins, centaurin-a1/ p42 IP4 ), might inhibit their membrane recruitment, activation, or protein interactions. However, until recently, the physiological relevance of these findings was unknown.
Lymphocytes predominantly express two Itpks, ItpkB and ItpkC (Vanweyenberg et al. 1995; Wen et al. 2004) . ItpkC is broadly expressed by many tissues. ItpkB expression appears restricted to hematopoietic cells and the brain (Wen et al. 2004; Jia et al. 2008a ). ItpkB-deficient mice recently unveiled the physiological importance of ItpkB in lymphocyte development and activation (Table 1) (Pouillon et al. 2003; Wen et al. 2004) . These mice are profoundly immunocompromised due to severe peripheral T-cell deficiency (Pouillon et al. 2003; Wen et al. 2004) , reduced numbers and defective activation of B cells (Marechal et al. 2007; Miller et al. 2007a; Miller et al. 2009) , and increased numbers of functionally perturbed neutrophils ). Several recent reviews describe current models for ItpkB function in B cells and neutrophils (Huang et al. 2008; Jia et al. 2008b; Miller et al. 2008; Sauer and Cooke 2010) . Here, we highlight the function of IP 4 in T cells.
ItpkB-deficient mice have a block of T-cell development due to defective positive selection (Pouillon et al. 2003; Wen et al. 2004) . Whether negative selection is affected is still unclear (Sauer and Cooke 2010) . Selected effectors of both IP 3 (Ca 2þ ) and DAG are specifically required for positive selection. Deficiency in Calcineurin B, a Ca 2þ -dependent phosphatase that activates NFAT (Neilson et al. 2004; Gallo et al. 2007 ), or in RasGRP1, partially blocks positive selection (Dower et al. 2000; Priatel et al. 2002) . Intriguingly, ItpkB deficiency blocks positive selection much more profoundly in a manner that depends on the ability of ItpkB to generate IP 4 (Huang et al. 2007 ). Normal IP 3 levels and Ca 2þ mobilization in ItpkB-deficient thymocytes argue against significant contributions by these messengers. Instead, the block results from an inability of ItpkB-deficient thymocytes to produce sufficient DAG amounts in response to mild, positively selecting TCR stimuli (Huang et al. 2007) . Consequently, mild TCR engagement induced Ras/Erk activation is impaired in ItpkB-deficient DP cells. This likely contributes to defective positive selection (Starr et al. 2003; McGargill et al. 2009 ). Addition of the DAG analog, PMA, restored Erk activation and allowed ItpkB-deficient CD4 and CD8 Tcell maturation (Huang et al. 2007 Mechanistic analyses revealed that IP 4 is required for membrane recruitment and subsequent activation of the TFK Itk following mild TCR stimulation (Huang et al. 2007 ). This was surprising since generation of PIP 3 , the established membrane ligand for the Itk PH domain, was thought to be the limiting factor for Itk membrane localization. In vitro analyses then showed that low mM IP 4 concentrations, as previously found in TCR-stimulated T cells (Imboden and Pattison 1987) , promoted Itk or Itk-PH-domain binding to PIP 3 (Huang et al. 2007 ). Very high, likely super-physiological IP 4 concentrations, competed with PIP 3 binding. The ability of the Itk-PH domain to oligomerize (Huang et al. 2007) (Sauer and Cooke 2010) . These findings identified Itk as the first physiological IP 4 "receptor" and unveiled the first physiological IP 4 function as a second messenger that controls Itk membrane recruitment and activation downstream of the TCR (Irvine 2007) . They suggest that IP 4 and PIP 3 act as partners where soluble IP 4 controls the ability of its membrane lipid counterpart to interact with the Itk-PH domain. It is exciting to hypothesize that this new principle of regulating PH-domain function through an interplay of a soluble IP and its phosphoinositide-lipid partner has broader relevance in biological signaling. Indeed, IP 4 could have similar bimodal effects on PIP 3 binding to the Tec-and RASA3-PH domains, but whether this is physiologically relevant still needs to be determined (Huang et al. 2007 ). In neutrophils, IP 4 has recently been suggested to inhibit Akt-PH domain interactions with membrane PIP 3 or PI(3,4)P 2 . Loss of this function may contribute to an accumulation of granulocyte-macrophage progenitors and functionally-impaired neutrophils in ItpkB 2/2 mice Jia et al. 2008a; Jia et al. 2008b ). On the other hand, IP 4 did not affect PLCg1 binding to PIP 3 , which is mediated through its classic-and split-PH domains (Fig. 2) (Huang et al. 2007 ). Thus, not all PIP 3 -binding PH domains may be subject to IP 4 control. One possible explanation is that the affinities of a given PH domain for PIP 3 and IP 4 can differ, with some PH domains preferring IP 4 or PIP 3 , possibly due to differential contributions of the 1-phosphate or the lipid environment to the binding free energy (DiNitto and Lambright 2006) .
Finally, it is important to keep in mind that IP 4 can be a precursor for multiple soluble IPs in mammalian cells. Some of these have been found in lymphocytes (for reviews, see Sauer et al. 2009; Sauer and Cooke 2010) . Hence, some aspects of the ItpkB 2/2 phenotype might reflect deficiencies in other IPs.
Due to the blocked T-cell development in ItpkB-deficient mice, analyses of specific ItpkB functions in peripheral T cells will require conditionally ItpkB-deficient mice. However, studies linking ItpkC loss-of-function to augmented Jurkat cell activation and human Kawasaki disease support an IP 4 role in regulating peripheral T-cell activation (Onouchi et al. 2008 ).
PHOSPHATASES CONTROL PIP 3 AND IP 4 TURNOVER PIP 3 levels are down-regulated by lipid phosphatases, including PTEN and SHIP1/2 in lymphocytes ( Figs. 1 and 3 ; Table 1 ) (Harris et al. 2008) . PTEN reverses the PI3K reaction and is generally thought to limit PI3K function. SHIP1/2 remove the PIP 3 5-phosphate, generating PI(3,4)P 2 and also down-modulating PIP 3 levels (Damen et al. 1996; Kavanaugh et al. 1996; Lioubin et al. 1996) . However, effectors such as Akt that predominantly bind to the inositol 3/4-phosphates may continue to be recruited and activated by PI(3,4)P 2 . Thus, differential use of PTEN and SHIP1/2 can selectively alter the activities of a subset of PIP 3 effectors, qualitatively changing PI3K responses.
Complete PTEN deficiency in mice results in embryonic lethality (Di Cristofano et al. 1998 ). PTEN hemizygosity, or conditional deficiency caused T-cell hyperproliferation, autoimmunity, and increased tumor incidence (Di Cristofano et al. 1999; Di Cristofano and Pandolfi 2000) . PTEN deletion in T cells revealed the importance of precise PIP 3 regulation for T-cell development through defective positive and negative selection (Suzuki et al. 2001) . PTEN-deficient peripheral T cells were hyperresponsive to suboptimal TCR stimulation and less dependent on co-stimulation, resulting in autoimmune pathology (Suzuki et al. 2001) . Activated T cells secreted increased cytokine amounts (Suzuki et al. 2001 ) and showed a bias toward the T H 2 lineage (Buckler et al. 2008) . Thus, PIP 3 down-regulation by PTEN is required for limiting T-cell responses and maintaining self-tolerance.
PIP 3 dephosphorylation at the 5-position by SHIP1/2 is also important for T-cell tolerance. However, while the effects of SHIP deficiency partially overlap with those of PTEN deficiency, the additional importance of generating PI(3,4)P 2 is evident from the additional shortened lifespan of SHIP-deficient mice (Helgason et al. 1998) . SHIP-deficient CD4 T cells have an altered Th1/Th2 cell ratio. SHIPdeficient CD8 T cells are less cytotoxic (Tarasenko et al. 2007 ). Thus far, these phenotypes have been attributed to defective PIP 3 conversion into PI(3,4)P 2 .
However, in vitro, both SHIPs and PTEN can dephosphorylate IP 4 into I(1,3,4)P 3 or Ins(1,4,5)P 3 , respectively ( Fig. 1) Maehama and Dixon 1998; Pesesse et al. 1998; Caffrey et al. 2001) . Whether this is relevant in vivo is unknown. If it were, then the phenotypes of PTEN 2/2 or SHIP 2/2 mice might need reinterpretation to consider potential contributions of perturbed IP 4 downregulation. On the other hand, the presence of an IP 4 -inhibited 5-phosphatase in Jurkat cells that lack SHIP and PTEN (and also show hyperactivation) suggests that other phosphatases might also regulate IP 4 levels in T cells (Hermosura et al. 2000) .
CONCLUDING REMARKS
We have highlighted the importance of phosphoinositol signaling in lymphocytes, focusing on T cells. The importance of phosphoinositide lipids and of the Ca 2þ -mobilizing soluble I(1,4,5)P 3 in lymphocyte signaling have long been established, although many open questions remain. For example, what influence do the specific fatty acids in a phosphoinositide have? There is evidence that many different fatty acids can be found in a given phosphoinositide isomer. They might control where it is located or other aspects of its function. Is PIP 3 really a universe of diverse molecules that differ in their fatty acid moieties and, possibly, functions?
More recent data unveiled important functions for the lipids DAG and PA, and for soluble IP 4 in lymphocyte development and function. Some insight into the molecular mechanisms through which these novel messengers act has been gained, but our understanding of their molecular functions is far from complete. In particular, the roles of additional DAG effectors other than RasGRPs and PKCs in T cells need assessment, and the molecular mechanisms through which PA contributes to DGK function in lymphocytes are only beginning to be understood .
One of the most intriguing, possibly broadly relevant, recent findings is the ability of IP 4 to control PIP 3 interactions with its effectors. Because PIP 3 is the key mediator of PI3K, PTEN, and SHIP function, IP 4 might ultimately act to control the functions of these important enzymes. Biochemically, PI3K and IP3Ks catalyze the very same reaction: phosphorylation of the inositol 3-position. Physiologically, they create the Tessa Virtue and Scott Moir, respectively, of a couple of second messengers whose dance in the cellular ice ring is reminiscent of the intricacy and elegance of its 2010 Winter Olympics counterpart. In DP thymocytes, the dance establishes a feedback loop of Itkmembrane recruitment and PLCg1 activation that is essential to allow mild TCR stimuli to cause sufficient DAG production, such that Ras/Erk can be activated and trigger positive selection (Huang et al. 2007; Sauer and Cooke 2010) . It will be important to explore how broadly relevant PIP 3 control through soluble IP 4 is in other cell types and downstream of other receptors. Moreover, clarifying what determines whether a PIP 3 -binding protein domain is subject to IP 4 control remains a challenging and important question. Finally, it will be exciting to determine the functions of the other higher-order IPs found in lymphocytes (Sauer et al. 2009; Sauer and Cooke 2010) , and to determine which ones are IP 4 -derived and might, thus, mediate aspects of IP 4 function. Clearly, exploring phosphoinositide-lipid signaling and the functions of the soluble IP code in lymphocytes will remain an exciting and important research area for years to come.
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